Epinephrine Auto-Injector 0.15 mg Injection Syringe 0.15 mL (2-Pack)

Epinephrine Auto-Injector 0.15 mg is used for the emergency treatment of severe allergic reactions (anaphylaxis) in individuals, particularly in children who weigh 15 to 30 kg (33 to 66 lbs). This life-saving device delivers a precise dose of epinephrine to counteract symptoms like difficulty breathing, swelling, or a drop in blood pressure. It works rapidly to stabilize the cardiovascular system and reduce allergic response, buying critical time until medical assistance is available. Immediate administration is crucial to prevent life-threatening outcomes.

Anneal Pharmaceuticals Epinephrine 0.15 mg Injection Auto-Injector Pen 0.15 mL. NDC: 00115-1695-49 Adrenergic Agonist.

The Epinephrine Auto-Injector 0.15 mg by Anneal Pharmaceuticals offers swift and reliable emergency treatment for life-threatening allergic reactions, known as anaphylaxis. This user-friendly, pre-filled auto-injector is engineered for immediate use and is specifically designed to deliver a precise dose of epinephrine for pediatric patients or individuals weighing 15 to 30 kg (33 to 66 lbs). The pack includes two 0.15 mL auto-injectors, ensuring that a follow-up dose is readily available if necessary. Known for its straightforward operation and portability, this essential medication is a critical component of any allergy management plan.

Product Details and Features

Dosage Strength: 0.15 mg of Epinephrine per 0.15 mL injection
Packaging: Two auto-injectors per pack for primary and backup use
Design: Compact, portable, and easy-to-use for rapid administration
Activation: Automatic needle injection with safety guard to minimize needle exposure
Manufacturer: Anneal Pharmaceuticals, a trusted leader in acute care solutions

Mechanism of Action

Epinephrine, a non-selective adrenergic agonist, works by stimulating α- and β-adrenergic receptors. This dual-action mechanism results in vasoconstriction and bronchodilation, effectively counteracting hypotension, bronchospasm, and upper airway edema associated with anaphylaxis. Moreover, epinephrine diminishes vasodilation and vascular permeability, preventing further progression of allergic symptoms and stabilizing the patient’s condition swiftly.

Directions for Use

1. Indication: For emergency intramuscular use in patients experiencing anaphylaxis.
2. Instructions: Grip the auto-injector in your dominant hand.

• Pull off the safety cap and inject into the outer thigh, holding in place for several seconds. The injection can be administered through clothing if necessary.
• Massage the injection area for 10 seconds to promote epinephrine distribution.

3. Repeat Use: Seek emergency medical help immediately, even if symptoms improve. Administer the second auto-injector if symptoms persist after five to fifteen minutes.

Ensure that patients and caregivers are trained in the proper use of the auto-injector.

Warnings

• Allergy and Medication Conditions: Inform your healthcare provider of any allergies, medications, or cardiovascular conditions.
  
• Misuse Risk: Administer only when anaphylaxis is suspected; improper use could lead to serious side effects.
  
• Storage: Store at room temperature, away from light and out of reach of children. Ensure product is not expired.

Side Effects

While epinephrine administration is crucial for emergency anaphylaxis treatment, potential side effects may occur, including:

• Common: Anxiety, restlessness, tremors, and palpitations
  
• Cardiovascular: Rapid heart rate, arrhythmias, or hypertension
  
• Neurological: Dizziness or headache
  
• Site Reactions: Redness, swelling, or pain at the injection site

Serious adverse events are rare but possible, especially in patients with underlying heart conditions.

Disclaimer

This information provides an educational overview for healthcare providers and caregivers; detailed guidance from a medical professional is essential for its safe, effective use. Make sure to review the full prescribing information and safety warnings that accompany the Epinephrine Auto-Injector 0.15 mg before patient use.